Mycobacterium tuberculosis
"Mycobacterium tuberculosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation.
| Descriptor ID |
D009169
|
| MeSH Number(s) |
B03.510.024.049.525.500.702 B03.510.460.400.410.552.552.702
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Mycobacterium tuberculosis".
Below are MeSH descriptors whose meaning is more specific than "Mycobacterium tuberculosis".
This graph shows the total number of publications written about "Mycobacterium tuberculosis" by people in this website by year, and whether "Mycobacterium tuberculosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 1 | 1 |
| 1998 | 3 | 0 | 3 |
| 2001 | 2 | 0 | 2 |
| 2002 | 0 | 1 | 1 |
| 2003 | 1 | 0 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 1 | 1 | 2 |
| 2006 | 5 | 2 | 7 |
| 2007 | 3 | 0 | 3 |
| 2008 | 4 | 2 | 6 |
| 2009 | 1 | 3 | 4 |
| 2010 | 4 | 1 | 5 |
| 2011 | 4 | 5 | 9 |
| 2012 | 4 | 2 | 6 |
| 2013 | 6 | 2 | 8 |
| 2014 | 9 | 1 | 10 |
| 2015 | 13 | 3 | 16 |
| 2016 | 7 | 4 | 11 |
| 2017 | 7 | 4 | 11 |
| 2018 | 6 | 1 | 7 |
| 2019 | 6 | 4 | 10 |
| 2020 | 13 | 2 | 15 |
| 2021 | 8 | 1 | 9 |
| 2022 | 7 | 1 | 8 |
| 2023 | 9 | 0 | 9 |
| 2024 | 8 | 0 | 8 |
| 2025 | 4 | 3 | 7 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Mycobacterium tuberculosis" by people in Profiles.
-
Mast cells promote pathology and susceptibility in tuberculosis. Elife. 2026 Jan 28; 13.
-
Targeting the lung innate pathways during tuberculosis can improve vaccine-induced protection via Th17 responses in diversity outbred mice. mBio. 2026 02 11; 17(2):e0323225.
-
Concurrent TB and HIV therapies control TB reactivation during co-infection but not chronic immune activation. Nat Commun. 2025 Dec 12; 17(1):499.
-
Development and preclinical evaluation of next-generation ?sigH-based live candidate vaccines. JCI Insight. 2025 10 08; 10(19).
-
Disruption of riboflavin biosynthesis in mycobacteria establishes riboflavin pathway intermediates as key precursors of MAIT cell agonists. PLoS Pathog. 2025 07; 21(7):e1012632.
-
Structural insights into terminal arabinosylation of mycobacterial cell wall arabinan. Nat Commun. 2025 Apr 29; 16(1):3973.
-
Mechanistic studies of mycobacterial glycolipid biosynthesis by the mannosyltransferase PimE. Nat Commun. 2025 Apr 29; 16(1):3974.
-
Prevention of tuberculosis in cynomolgus macaques by an attenuated Mycobacterium tuberculosis vaccine candidate. Nat Commun. 2025 Feb 25; 16(1):1957.
-
Different chemical scaffolds bind to L-phe site in Mycobacterium tuberculosis Phe-tRNA synthetase. Eur J Med Chem. 2025 Apr 05; 287:117335.
-
Nuclear Factor ?B Signaling Deficiency in CD11c-Expressing Phagocytes Mediates Early Inflammatory Responses and Enhances Mycobacterium tuberculosis Control. J Infect Dis. 2024 Aug 16; 230(2):336-345.